208 related articles for article (PubMed ID: 34699874)
1. An update on factor XII-driven vascular inflammation.
Mailer RK; Rangaswamy C; Konrath S; Emsley J; Renné T
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119166. PubMed ID: 34699874
[TBL] [Abstract][Full Text] [Related]
2. Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice.
Vorlova S; Koch M; Manthey HD; Cochain C; Busch M; Chaudhari SM; Stegner D; Yepes M; Lorenz K; Nolte MW; Nieswandt B; Zernecke A
Thromb Haemost; 2017 Jan; 117(1):176-187. PubMed ID: 27786338
[TBL] [Abstract][Full Text] [Related]
3. Factor XII in coagulation, inflammation and beyond.
Didiasova M; Wujak L; Schaefer L; Wygrecka M
Cell Signal; 2018 Nov; 51():257-265. PubMed ID: 30118759
[TBL] [Abstract][Full Text] [Related]
4. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
Schousboe I
Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
[TBL] [Abstract][Full Text] [Related]
6. Factor XII truncation accelerates activation in solution.
de Maat S; Clark CC; Boertien M; Parr N; Sanrattana W; Hofman ZLM; Maas C
J Thromb Haemost; 2019 Jan; 17(1):183-194. PubMed ID: 30394658
[TBL] [Abstract][Full Text] [Related]
7. In vivo roles of factor XII.
Renné T; Schmaier AH; Nickel KF; Blombäck M; Maas C
Blood; 2012 Nov; 120(22):4296-303. PubMed ID: 22993391
[TBL] [Abstract][Full Text] [Related]
8. Mechanism, Functions, and Diagnostic Relevance of FXII Activation by Foreign Surfaces.
Konrath S; Mailer RK; Renné T
Hamostaseologie; 2021 Dec; 41(6):489-501. PubMed ID: 34592776
[TBL] [Abstract][Full Text] [Related]
9. The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities.
Worm M; Köhler EC; Panda R; Long A; Butler LM; Stavrou EX; Nickel KF; Fuchs TA; Renné T
Ann Transl Med; 2015 Oct; 3(17):247. PubMed ID: 26605293
[TBL] [Abstract][Full Text] [Related]
10. Contact system revisited: an interface between inflammation, coagulation, and innate immunity.
Long AT; Kenne E; Jung R; Fuchs TA; Renné T
J Thromb Haemost; 2016 Mar; 14(3):427-37. PubMed ID: 26707513
[TBL] [Abstract][Full Text] [Related]
11. Roles of Factor XII in Innate Immunity.
Renné T; Stavrou EX
Front Immunol; 2019; 10():2011. PubMed ID: 31507606
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in factor XII structure and function.
Shamanaev A; Litvak M; Gailani D
Curr Opin Hematol; 2022 Sep; 29(5):233-243. PubMed ID: 35916558
[TBL] [Abstract][Full Text] [Related]
14. Factor XII: a novel target for safe prevention of thrombosis and inflammation.
Kenne E; Nickel KF; Long AT; Fuchs TA; Stavrou EX; Stahl FR; Renné T
J Intern Med; 2015 Dec; 278(6):571-85. PubMed ID: 26373901
[TBL] [Abstract][Full Text] [Related]
15. Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation.
Clermont AC; Murugesan N; Edwards HJ; Lee DK; Bayliss NP; Duckworth EJ; Pethen SJ; Hampton SL; Gailani D; Feener EP
Front Pharmacol; 2023; 14():1287487. PubMed ID: 38178859
[No Abstract] [Full Text] [Related]
16. Rapid and cooperative binding of factor XII to human umbilical vein endothelial cells.
Schousboe I
Eur J Biochem; 2001 Jul; 268(14):3958-63. PubMed ID: 11453989
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function.
Liu J; Cooley BC; Akinc A; Butler J; Borodovsky A
Thromb Res; 2020 Dec; 196():200-205. PubMed ID: 32896690
[TBL] [Abstract][Full Text] [Related]
19. Factor XII Contact Activation.
Naudin C; Burillo E; Blankenberg S; Butler L; Renné T
Semin Thromb Hemost; 2017 Nov; 43(8):814-826. PubMed ID: 28346966
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary study on the effects of coagulation factor XII on fibrinolysis].
Hu Y; Wang H; Jiao J; Wang Y; Yu W; Ling X
Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):466-8. PubMed ID: 11877020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
